Our study focused on the modulatory effect of fingolimod (FTY720) on the age-dependent gene expression profile of enzymes and receptors engaged in S1P/ceramide signaling and anti-apoptotic Bcl-2 protein in brain parts of transgenic AD mice. Here, BCL2 is linked to Alzheimer disease.